The research, led by Stony Brook University and published recently, analyzed 227 World Trade Center (WTC) responders who developed Neurological Post-Acute Sequelae COVID (N-PASC). By comparing blood samples taken before the pandemic to those taken months or years after infection, the team discovered a 59% increase in plasma tau levels.
A Biological Marker for Brain Damage
Tau is a crucial protein found in the brain's nerve cells. While essential in normal amounts, excess levels—particularly the "phosphorylated" pTau-181 variant—are known biomarkers for lasting brain damage and cognitive decline.
Dr. Sean Clouston, a professor at Stony Brook University’s Renaissance School of Medicine, explained that elevated blood levels of tau serve as a recognized indicator of permanent brain injury. He noted that the study’s findings suggest long COVID might become more severe over time, potentially causing neurological symptoms to evolve or leading to a progressive decline in cognitive function.
Key Findings of the Study:
Time is a factor: For patients experiencing neurocognitive symptoms for more than 1.5 years, the tau increases were even more pronounced, suggesting that the condition may intensify as patients age.
The Control Group: The study compared the N-PASC group against 227 others who either didn't catch COVID or caught it without developing long-term symptoms. This control group showed no significant increase in tau levels.
Long-Term Horizon: Measurements were taken at an average of 2.2 years post-infection, with some samples taken up to four years later, representing a true long-term look at the virus's aftermath.
Broader Implications
While the results are significant, researchers caution that more work is needed. Because the participants were WTC responders, they have a history of unique environmental exposures that might differ from the general public. The next step involves using neuroimaging (such as PET scans) to see if the high tau levels in the blood correspond to high levels in the brain.
Dr. Benjamin J. Luft, Director of the WTC Health and Wellness Program, noted the gravity of the find: "This is one of the first studies to show that a virus may contribute to the development of abnormal tau production over time." He added that these findings underscore the urgent need for effective vaccines and therapies to prevent acute infections from embedding themselves and causing long-term neurocognitive decay.
Disclaimer: This content is published only for health awareness and informational purposes. It's not a substitute for your professional medical advice. You must consult a doctor/healthcare professional regarding your specific health concerns.
0 Comments